Search Results

Radiopharma AAA refiles for up to $75M IPO; Sterigenics does $15M expansion;

million. It had previously filed for up to $100 million in November 2014. More > Medical device ...

Glaxo's consumer health CEO lays out blueprint for margin turnaround

as it works to turn sales around Post-Novartis deal, GSK's top dog in vaccines, consumer health. Now ...

Novocure makes it out with a $165M downsized IPO, trades down 10%

Med tech IPOs fall into place: Penumbra, Symetis, Novocure and Adesto Novocure files for up to $300M ...

On second thought, Amicus won't be filing its lead drug this year

Articles: Amicus plots an end-of-year FDA filing for its resuscitated lead drug Amicus bags PhIII rare ...

Novartis comes for Enbrel in latest biosimilar shot at Amgen

its repertoire of biosimilars, believes it is the first company to successfully file an application ...

Daiichi Sankyo expands its OTC reach; Mylan to prohibit sales of drug for executions;

of the first liquid dose aspirin is looking for a partner. Report > French vaccine maker Abivax is conducting clinical trials on a hepatitis C vaccined developed in Cuba. Story Medical Device News ...

USDA: Deadly pig virus likely carried into U.S. from China

of virulent PEDv found on Minnesota hog farm USDA gives conditional approval for Zoetis PEDv vaccine PEDv ...

Apple is developing an electronic ring full of biosensors

features mentioned in the filing are also in, or planned for, the Apple Watch. So, it may indicate ...

EMA management board nominates Rasi as exec director; FDA approves Allergan's Juvederm in lips;

deal.  Article Vaccines News > Novavax's RSV jab protects infants in PhII, nets $89M Gates Foundation grant.  Article > Advaxis targets HER2 cancers with first-in-human vaccine trial.  Story > ...

Biotech's Wall Street swoon mutes IPOs for Edge and Mirna

filing ...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • next ›
  • last »